Biotech Brief: Demand is Growing for Safer, More-Efficacious Drugs When Treating Pancreatic Cancer
Palm Beach, FL –January 27, 2020 – In the pancreatic cancer, the search is on for safer more efficacious drugs. As per the American’s Cancer Society Cancer Facts and Figures report, by the end of the year 2019, over 56,700 Americans will be diagnosed with pancreatic cancer. A recent research article says that the pancreatic […]
Escalating Global Demand & Increased Consumption Of Copper To Drive Revenues In 2020
Palm Beach, FL –January 27, 2020 – Various industry publications from around the world point out that global demand for copper metal (produced from refined copper and recycled scrap) is projected to advanced 4.2 percent per year through 2019 to 36.0 million metric tons, valued at $261 Billion. In this year, robust gains in building […]
Oncolytics Biotech® Announces Statistically Significant Data Demonstrating the Potential of CEACAM6 as a Prognostic Biomarker for Pelareorep in the Treatment of Pancreatic Adenocarcinoma
Over 80% improvement in progression free survival in patients with low levels of CEACAM6 San Diego and Calgary, AB – January 27, 2020 — Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announced that a poster presentation highlighting statistically significant data demonstrating that CEACAM6 is a […]
LOS ANDES COPPER LTD. ANNOUNCES COMPLETION OF NSR ROYALTY AGREEMENT WITH RESOURCE CAPITAL FUND
Vancouver, BC – January 27, 2020- Los Andes Copper Ltd. (TSX-V: LA) (“Los Andes”, or the “Company”) is pleased to announce that it has entered into a net smelter return (“NSR”) financing agreement with Resource Capital Fund VI L.P (“RCF”) pursuant to which the Company will receive US$8 million (approximately CDN$10,500,000) from RCF, as consideration […]
